Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>>NEW! Download now...

ShangPharma Buys Charles River’s Shanghai Lab

publication date: Oct 24, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
ShangPharma acquired the Shanghai research facility formerly owned by Charles River Labs. The purchase will allow ShangPharma’s main subsidiary, Shanghai ChemPartner, to expand its GLP tox study capacity. The lab comprises 31,990 square feet of in-vivo research facilities, which were designed for GLP tox studies, plus another 13,885 square feet of lab and office space. More details....

Stock Symbols: (NYSE: SHP) (NYSE: CRL)

Share this with colleagues:  

This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events


BioPacific Conference 2012
June 2, 2012
California, USA

  China Forum 2012
  November 11, 2012
Hamburg, Germany

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners